{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T00:18:09.839398+00:00","published_at":"2026-10-16T13:53:41.002909+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:dg087jy0i5d5","event_type":"CFO_CHANGED","effective_at":"2026-02-13","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:lori-macomber-c-p-a","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:ef57edc74878702f0811eb60506abe98b397e61fcb61228ed2035004473d9998"],"summary":"Lori Macomber, C.P.A. executive of Karyopharm Therapeutics Inc., effective 2026-02-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ly8mbdv96ctb","event_type":"GC_CHANGED","effective_at":"2026-02-13","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:mary-l-rotunno-j-d","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:95bbbb22949333e43a16e220c74b7417526b35e1b53aad286439a1db79f79c02"],"summary":"Michael V. Greco, J.D. executive of Karyopharm Therapeutics Inc., effective 2026-02-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17jw31z18716kn","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-02-13","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:reshma-rangwala-m-d-ph-d","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:ebf994635e7040faf25c2ef37d8e18e57373479e98542000963e6ed2b050891a"],"summary":"Reshma Rangwala, M.D., Ph.D. executive of Karyopharm Therapeutics Inc., effective 2026-02-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:p9ze824jnlv4","event_type":"CEO_CHANGED","effective_at":"2026-02-13","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:richard-paulson-m-b-a","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:ec6923005a6d4380fe5376986884ab511b084d3bb22dd25f042ba65fc779d008"],"summary":"Richard Paulson, M.B.A. executive of Karyopharm Therapeutics Inc., effective 2026-02-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fb5mle7dbyzu","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-02-13","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:sohanya-cheng-m-b-a","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:0841f28528460d822d6f959f89aab8cc5a5d337dacae3e05f24f140b17638969"],"summary":"Sohanya Cheng, M.B.A. executive of Karyopharm Therapeutics Inc., effective 2026-02-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15k4p1f1jemc1f","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-02-13","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:stuart-poulton","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:6c6525bd39c9f21f19eb60a5b1f4790da4f8b8945f73bd80caba6c66645d655e"],"summary":"Stuart Poulton executive of Karyopharm Therapeutics Inc., effective 2026-02-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15oyqnq1qzzls","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:zhen-su-m-d-m-b-a","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Zhen Su, M.D., M.B.A. seat on Karyopharm Therapeutics Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1047dw92ag5wh","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:christy-j-oliger","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Christy J. Oliger seat on Karyopharm Therapeutics Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xfx14u61fpjo","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:chen-schor-m-b-a-c-p-a","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Cynthia L. Anderson, CPA seat on Karyopharm Therapeutics Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1o24k72148ob26","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:richard-paulson-m-b-a","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Richard Paulson, M.B.A. seat on Karyopharm Therapeutics Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:m9mfh27tzypu","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:barry-e-greene","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Barry E. Greene seat on Karyopharm Therapeutics Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16kpsm91gn3k37","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:deepika-r-pakianathan-ph-d","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Deepika R. Pakianathan, Ph.D. seat on Karyopharm Therapeutics Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18m6pdizn9nn2","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:garen-g-bohlin","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Garen G. Bohlin seat on Karyopharm Therapeutics Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:354kvu1bfk9me","event_type":"COMMITTEE_CREATED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:committee:karyopharm-therapeutics-inc:audit-chair-nominating-and-governance","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Audit · Chair; Nominating and Governance committee of Karyopharm Therapeutics Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xcbi9mftzz3q","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:garen-g-bohlin","alpha:committee:karyopharm-therapeutics-inc:audit-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Garen G. Bohlin member of Audit · Chair; Nominating and Governance, effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:131p3ig1ehbzxy","event_type":"COMMITTEE_CREATED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:committee:karyopharm-therapeutics-inc:compensation-nominating-and-governance-chair","alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Compensation; Nominating and Governance · Chair committee of Karyopharm Therapeutics Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:punw15n2vtwn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2013-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:barry-e-greene","alpha:committee:karyopharm-therapeutics-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848"],"summary":"Barry E. Greene member of Compensation; Nominating and Governance · Chair, effective 2013-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:5","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barry-e-greene","object_label":"Barry E. Greene","object_source_name_forms":[],"value":"Barry E. Greene: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:barry-e-greene","name":"Barry E. Greene"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:6","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christy-j-oliger","object_label":"Christy J. Oliger","object_source_name_forms":[],"value":"Christy J. Oliger: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christy-j-oliger","name":"Christy J. Oliger"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:7","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:chen-schor-m-b-a-c-p-a","object_label":"Cynthia L. Anderson, CPA","object_source_name_forms":[],"value":"Cynthia L. Anderson, CPA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:chen-schor-m-b-a-c-p-a","name":"Cynthia L. Anderson, CPA"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:8","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:deepika-r-pakianathan-ph-d","object_label":"Deepika R. Pakianathan, Ph.D.","object_source_name_forms":[],"value":"Deepika R. Pakianathan, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:deepika-r-pakianathan-ph-d","name":"Deepika R. Pakianathan, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:9","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:garen-g-bohlin","object_label":"Garen G. Bohlin","object_source_name_forms":[],"value":"Garen G. Bohlin: Director, Audit · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:garen-g-bohlin","name":"Garen G. Bohlin"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:10","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-paulson-m-b-a","object_label":"Richard Paulson, M.B.A.","object_source_name_forms":[],"value":"Richard Paulson, M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-paulson-m-b-a","name":"Richard Paulson, M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:11","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:zhen-su-m-d-m-b-a","object_label":"Zhen Su, M.D., M.B.A.","object_source_name_forms":[],"value":"Zhen Su, M.D., M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:zhen-su-m-d-m-b-a","name":"Zhen Su, M.D., M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-13","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:12","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lori-macomber-c-p-a","object_label":"Lori Macomber, C.P.A.","object_source_name_forms":[],"value":"Lori Macomber, C.P.A.: Executive Vice President, Chief Financial Officer and Treasurer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lori-macomber-c-p-a","name":"Lori Macomber, C.P.A."},"title":"Executive Vice President, Chief Financial Officer and Treasurer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-13","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ef57edc74878702f0811eb60506abe98b397e61fcb61228ed2035004473d9998","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:00.81631+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-13T00:00:00+00:00","effective_from":"2026-02-13","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:13","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mary-l-rotunno-j-d","object_label":"Michael V. Greco, J.D.","object_source_name_forms":[],"value":"Michael V. Greco, J.D.: Executive Vice President, Chief Legal Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mary-l-rotunno-j-d","name":"Michael V. Greco, J.D."},"title":"Executive Vice President, Chief Legal Officer and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-13","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:95bbbb22949333e43a16e220c74b7417526b35e1b53aad286439a1db79f79c02","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:01.289898+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-13T00:00:00+00:00","effective_from":"2026-02-13","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:14","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:reshma-rangwala-m-d-ph-d","object_label":"Reshma Rangwala, M.D., Ph.D.","object_source_name_forms":[],"value":"Reshma Rangwala, M.D., Ph.D.: Executive Vice President, Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:reshma-rangwala-m-d-ph-d","name":"Reshma Rangwala, M.D., Ph.D."},"title":"Executive Vice President, Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-13","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ebf994635e7040faf25c2ef37d8e18e57373479e98542000963e6ed2b050891a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:02.297546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-13T00:00:00+00:00","effective_from":"2026-02-13","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:15","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:richard-paulson-m-b-a","object_label":"Richard Paulson, M.B.A.","object_source_name_forms":[],"value":"Richard Paulson, M.B.A.: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:richard-paulson-m-b-a","name":"Richard Paulson, M.B.A."},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-13","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ec6923005a6d4380fe5376986884ab511b084d3bb22dd25f042ba65fc779d008","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:34:59.555981+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-13T00:00:00+00:00","effective_from":"2026-02-13","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:16","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sohanya-cheng-m-b-a","object_label":"Sohanya Cheng, M.B.A.","object_source_name_forms":[],"value":"Sohanya Cheng, M.B.A.: Executive Vice President, Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sohanya-cheng-m-b-a","name":"Sohanya Cheng, M.B.A."},"title":"Executive Vice President, Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-13","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:0841f28528460d822d6f959f89aab8cc5a5d337dacae3e05f24f140b17638969","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:00.128566+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-13T00:00:00+00:00","effective_from":"2026-02-13","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:17","subject_id":"alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:stuart-poulton","object_label":"Stuart Poulton","object_source_name_forms":[],"value":"Stuart Poulton: Executive Vice President, Chief Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:stuart-poulton","name":"Stuart Poulton"},"title":"Executive Vice President, Chief Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-13","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:6c6525bd39c9f21f19eb60a5b1f4790da4f8b8945f73bd80caba6c66645d655e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:01.797664+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-13T00:00:00+00:00","effective_from":"2026-02-13","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Karyopharm Therapeutics Inc. DEF 14A 2026-04-13","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm","source_date":"2026-04-13","retrieved_at":"2026-04-24T23:40:02.17+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ef57edc74878702f0811eb60506abe98b397e61fcb61228ed2035004473d9998","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:00.81631+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:95bbbb22949333e43a16e220c74b7417526b35e1b53aad286439a1db79f79c02","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:01.289898+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ebf994635e7040faf25c2ef37d8e18e57373479e98542000963e6ed2b050891a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:02.297546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ec6923005a6d4380fe5376986884ab511b084d3bb22dd25f042ba65fc779d008","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:34:59.555981+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0841f28528460d822d6f959f89aab8cc5a5d337dacae3e05f24f140b17638969","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:00.128566+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6c6525bd39c9f21f19eb60a5b1f4790da4f8b8945f73bd80caba6c66645d655e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPTI 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm","source_date":"2026-02-13T00:00:00+00:00","retrieved_at":"2026-05-16T04:35:01.797664+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.846,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.896,"cross_source_agreement":0.75,"temporal_completeness":0.722},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":18,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:41.002909+00:00","observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":"2026-10-16T13:53:41.002909+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/karyopharm-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}